n-3 Fatty acids and the inflammatory response - Biological background

European Heart Journal, Supplement

Volumn 3, Issue SUPPL.4, 2001, Pages

  De Caterina, R ^a,b   Basta, G ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0012172164     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(01)90118-X     Document Type: Article

References (83)

1. Robbins S, Cotran R, Kumar V. Inflammation and repair processes. In: Pathologic Basis of Disease, 3rd edn. Philadelphia-London-Toronto: WB Saunders Co, 1984.
2. Henderson W. The role of leukotrienes in inflammation. Ann Intern Med 1994; 121: 684-97.
3. Ben-Baruch A, Michiel D, Oppenheim J. Signals and receptors involved in recruitment of inflammatory cells. J Biol Chem 1995; 270: 11703-6.
4. Simopoulos A. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54: 438-63.
5. De Caterina R, Endres S, Kristensen S, Schmidt E. n-3 Fatty Acids and Vascular Disease. Berlin: Springer, 1993: 167.
6. Kristensen S, Schmidt E, De Caterina R, Endres S. n-3 Fatty Acids: Prevention and Treatment in Vascular Disease. Berlin: Springer, 1995: 230.
7. Kristensen S, De Caterina R, Schmidt E, Endres S. Fish oil and ischaemic heart disease. Br Heart J 1993; 70: 212-4.
8. Knapp H, FitzGerald G. Anti-hypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supple-mentation in essential hypertension. N Engl J Med 1989; 320: 1037-43.
9. Appel I, Miller E, Seidler A, Whelton P. Does supplementation of diet with fish oil reduce blood pressure - a meta-analysis of controlled clinical trials. Arch Intern Med 1993; 153: 1429-38.
10. Schmidt E, Kristensen S, De Caterina R, Endres S. The effects of n-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis 1993; 103: 107-21.
11. Galli C, Butrum R. Dietary w3 fatty acids and cancer: an overview. In: Simopoulos A, Kifer R, Martin R, Barlow S, eds. Health effects of W w3 polyunsaturated fatty acids in seafoods. World Rev Nutr Diet 1991; 66: 446-61.
12. Malasanos T, Stacpoole P. Biological effects of w3 fatty acids in diabetes mellitus. Diabetes Care 1991; 14: 116-79.
13. De Caterina R, Endres S, Kristensen S, Schmidt F. n-3 Fatty acids and renal diseases. Am J Kidney Dis 1994; 24: 397-410.
14. Kromann N, Green A. Epidemiological studies in the Upernavik District, Greenland. Acta Med Scand 1980; 208: 401-6.
15. Dyerberg J, Bang H, Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 1975; 28: 958-66.
16. Bang H, Dyerberg J, Hjorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976; 200: 69-73.
17. Popp-Snijders C, Schouten J, van der Meer J, van der Veen E. Fatty-fish induced changes in membrane lipid composition and viscosity of human erythrocyte suspensions. Scand J Clin Invest 1986; 46: 253-8.
18. Singer P, Jaeger W, Voigt S, Thiel H. Defective desaturation and elongation of n-6 and n-3 fatty acids in hypertensive patients. Prostaglandins Leukot Med 1984; 15: 159-65.
19. Sharp J, White D, Chious X et al. Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. J Biol Chem 1991; 266: 14850-3.
20. Clark J, Lin L, Kriz R et al. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 1991; 65: 1043-51.
21. Mayer R, Marshall L. New insights on mammalian phospholipase A2(s); comparison of arachidonyl-selective and non-selective enzymes. FASEB J 1993; 7: 339-48.
22. Glaser Y, Mobilio D, Chang J, Senko N. Phospholipase A2 enzymes: regulation and inhibition. Trends Pharmacol Sci 1993; 14: 92-8.
23. Clark M, ÖgU L, Conway T, Dispoto J, Crooke S, Bomalaski J. Cloning of a phospholipase A2-activating protein. Proc Natl Acad Sci USA 1991; 88: 5418-22.
24. Kramer R, Hession C, Johansen B et al. Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem 1989; 264: 5768-75.
25. Leaf A, Weber P. Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988; 318: 549-57.
26. Knapp H. Omega-3 fatty acids in respiratory diseases: a review. J Am Coll Nutr 1995; 14: 18-23.
27. Patrono C, Ciabattoni G, Remuzzi G et al. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. J Clin Invest 1985; 76: 1011-8.
28. Ciabattoni G, Cinotti G, Pierucci A et al. Effect of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. N Engl J Med 1984; 310: 279-83.
29. Craven P, Melhem M, DeRubertis F. Thromboxane in the pathogenesis of glomerular injury in diabetes. Kidney Int 1992; 42: 937-46.
30. Perico N, Benigni A, Zoja C, Delaini F, Remuzzi G. Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A. Am J Physiol 1986; 251: F58I-7.
31. Foegh M, Lim K, Alijani M, Helfrich G, Ramweli P. Thromboxane and inflammatory cell infiltration in the allograft of renal transplant patients. Transplant Proc 1987; 19: 3633-6.
32. Remuzzi G, Imberti L, Rossini M et al. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis. J Clin Invest 1985; 75: 94-101.
33. Stahl R. Die Bedeutung von Eicosanoiden bei glomerulären Erkrankungen. Klin Wochenschr 1986; 64: 813-23.
34. Remuzzi G, FitzGerald G, Patrono C. Thromboxane synthesis and action within the kidney. Kidney Int 1992; 41: 1483-93.
35. De Caterina R, Caprioli R, Giannessi D et al. n-3 Polyunsaturated fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int 1993; 44: 843-50.
36. Dyerberg J, Bang H, Stofferson E, Moncada S, Vane J. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis. Lancet 1978; ii: 117-9.
37. von Schacky C, Fischer S, Weber P. Long-term effects of dietary marine ω-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoids formation in humans. J Clin Invest 1985; 76: 1626-31.
38. von Schacky C, Weber P. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest 1985; 76: 2446-50.
39. De Caterina R, Giannessi D, Mazzone A et al. Vascular prostacyclin is increased in patients ingesting omega-3 poly-unsaturated fatty acids before coronary artery bypass graft surgery. Circulation 1990; 82: 428-38.
40. Endres S, Ghorbany R, Kelley V et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-71.
41. Meydani S, Endres S, Wood M et al. Oral n-3 fatty acid supplementation suppresses cytokine production and lymphocyte proliferation. Comparison in young and older women. J Nutr 1991; 121: 547-55.
42. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of pro-atherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994; 14: 1829-36.
43. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P. Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostaglandins Leukot Essent Fatty Acids 1995; 52: 192-5.
44. De Caterina R, Libby P. Control of endothelial leukocyte adhesion molecules by fatty acids. Lipids 1996; 31 (Suppl 1): 557-63.
45. Weber C, Erl W, Pietsch A, Danesch U, Weber P. Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 1995; 15: 622-8.
46. Bauerle P. The inducible transcription activator NF-KB: regulation by distinct protein subunits. Biochim Biophys Acta 1991; 1072: 63-80.
47. Collins T. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest 1993; 68: 499-508.
48. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 1995; 9: 899-909.
49. Hansen J, Olsen J, Wilsgard I, Osterud B. Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis. J Intern Med Suppl 1989; 225: 133-9.
50. Tremoli E, Eligini S, Colli S et al. Effects of omega 3 fatty acid ethyl esters on monocyte tissue factor expression. World Rev Nutr Diet 1994; 76: 55-9.
51. Fox P, DiCorleto P. Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein. Science 1988; 241: 453-6.
52. Kaminski W, Jendraschak E, Kiefl R, von Schacky C. Dietary omega-3 fatty acids lower levels of platelet-derived growth factor MRNA in human mononuclear cells. Blood 1993; 71: 1871-9.
53. Habib A, Lubrano L, Basta G et al. n-3 polyunsaturated fatty acids inhibit COX-2 expression. Abstract 1103 from the XVIIth Congress of the International Society on Thrombosis and Haemostasis, Washington, DC, USA, August 14-21, 1999. Thromb Haemost 1999; 82 (Suppl): 348.
54. Habib A, Lubrano L, Basta G et al. n-3 polyunsaturated fatty acids inhibit COX-2 expression. Abstract 1103 from the XVIIth Congress of the International Society on Thrombosis and Haemostasis, Washington, DC, USA, August 14-21, 1999. Thromb Haemost 1999; 82 (Suppl): 348.
55. Lee T, Hoover R, Williams J et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985; 312: 1217-24.
56. Schmidt E, Dyerherg J. n-3 Fatty acids and leukocytes. J Intern Med 1989; 225 (Suppl 1): 151-58.
57. Schmidt E, Pedersen J, Ekelund S, Grunnet N, Jersild C, Dyerberg J. Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males. Atherosclerosis 1989; 77: 53-7.
58. Schmidt E, Pedersen J, Varming K et al. n-3 Fatty acids and leukocyte chemotaxis. Effects in hyperlipidemia and dose-response studies in healthy men. Arterioscler Thromb 1991; 11: 429-35.
59. Fisher M, Upchurch K, Levine P et al. Effects of dietary fish oil supplementation on polymorphonuclear leucocyte inflammatory potential. Inflammation 1986; 10: 387-92.
60. Terano T, Hirai A, Hamazaki T et al. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis 1983; 46: 321-31.
61. Cartwright I, Pockley A, Galloway J, Greaves M, Preston F. The effects of dietary w3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. Atherosclerosis 1985; 55: 267-81.
62. Ernst F. Effects of n-3 fatty acids on blood rheology. J Intern Med 1989; 225 (Suppl 731): 129-33.
63. Popp-Snijders C, Schouten J, van Blitterswijk W, van der Veen E. Changes in the membrane lipid composition of human erythrocytes after dietary supplementation of (n-3) polyunsaturated fatty acids. Maintenance of membrane fluidity. Biochim Biophys Acta 1986; 854: 31-6.
64. Hostmark A, Bjerkedal T, Kierulf P, Flaten H, Ulshagen K. Fish oil and plasma fibrinogen. Br Med J 1988; 297: 180-1.
65. Radak K, Deck C, Huster G. Dietary supplementation with low-dose fish oils lowers fibrinogen levels: a randomized, double-blind controlled study. Ann Intern Med 1989; 111: 757-8.
66. Flaten H, Hostmark A, Kierulf P et al. Fish-oil concentrate. Effects on variables related to cardiovascular disease. Am J Clin Nutr 1990; 52: 300-6.
67. Boulanger C, Schini V, Hendrickson H, Vanhoutte P. Chronic exposure of cultured endothelial cells to eicosapentaenoic acid potentiates the release of endothelium-dependent relaxing factor(s). Br J Pharmacol 1990; 99: 176-80.
68. Vanhoutte P, Shimokawa H, Boulanger C. Fish oil and the platelet-blood vessel wall interaction. World Rev Nutr Diet 1991; 66: 233-44.
69. Coddee J, Croft E, Barden A, Mathews E, Vandongen R, Beilin L. An inhibitory effect of dietary polyunsaturated fatty acids on renin secretion in the isolated perfused rat kidney. J Hypertens 1984; 2: 265-70.
70. Goodfriend T, Ball D. Fatty acids effects on angiotensin receptors. J Cardiovasc Pharmacol 1986; 8: 1276-83.
71. Sellmayer A, Obermeier H, Weber C, Weber P. Modulation of cell activation by n-3 fatty acids. In: De Caterina R, Endres S, Kristensen S, Schmidt E, eds. n-3 Fatty Acids and Vascular Disease. Berlin: Springer-Verlag, 1993: 21-30.
72. Weber C, Aepfelbacher M, Lux I, Zimmer B, Weber P. Docosahexaenoic acid inhibits PAF and LTD4-stimulated [Ca++]i increase in differentiated monocytic U937 cells. Biochim Biophys Acta 1991; 1133: 38-45.
73. Locher R, Sachinidis A, Brunner C, Vetter W. Intracellular free calcium concentration and thromboxane A2 formation of vascular smooth muscle cells are influenced by fish oil and n-3 eicosapentaenoic acid. Scand J Lab Invest 1991; 51: 541-7.
74. Hallaq H, Smith T, Leaf A. Protective effect of eicosapentaenoic acid on ouabain toxicity in neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 1990; 87: 7834-8.
75. Hallaq H, Smith T, Leaf A. Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proc Natl Acad Sci USA 1992; 89: 1760-4.
76. Swann P, Parent C, Croset M et al. Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function. J Biol Chem 1990; 265: 21692-7.
77. Ehringer W, Belcher D, Wassal S, Stillweli W. A comparison of the effects of linolenic (18:3 w3) and docosahexaenoic (22:6 w3) acids on phospholipid bilayers. Chem Phys Lipids 1990; 54: 79-88.
78. Salem N, Kim H, Yergey J. Docosahexaenoic acid: membrane function and metabolism. In: Simopoulos A, Kifer R, Martin R, eds. Health Effects of Polyunsaturated Fatty Acids in Seafoods. Orlando, FL: Academic Press, 1986: 263-318.
79. Medini L, Colli S, Mosconi C, Tremoli E, Galli C. Diets rich in n-9, n-6 and n-3 fatty acids differentially affect the generation of inositol phosphates and of thromboxane by stimulated platelets in the rabbit. Biochem Pharmacol 1990; 39: 129-33.
80. Locher R, Sachinidis A, Steiner A, Vogt E, Vetter W. Fish oil affects phosphoinositide turnover and thromboxane A metabolism in cultured vascular smooth cells. Biochim Biophys Acta 1989; 1012: 279-83.
81. 2+ from intracellular stores. Biol Chem 1991; 266: 4295-302.
82. Oliw E, Sprecher H. Metabolism of polyunsaturated (n-3) fatty acids by monkey seminal vesicles: isolation and biosynthesis of w3 epoxides. Biochim Biophys Acta 1991; 1086: 287-94.
83. Voss A, Reinhart M, Sankarappa S, Sprecher H. The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7, 10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturate. J Biol Chem 1991; 266: 19995-20000.